Medication info
Kretrol Tablet 10/5 mg

Kretrol Tablet 10/5 mg

Prescription medicationTabletOral
Ingredient · strength
Rosuvastatin Calcium›5.2mg / 1 tabletEzetimibe›10mg / 1 tablet
Manufacturer / importer
Aju Pharmaceutical Co., Ltd.
Appearance
White to almost white round film-coated tablet
Packaging
Blister - 30 tablets/blister [10 tablets/blister × 3], Bottle - 30 tablets/bottle, Bottle - 300 tablets/bottle
Approval status
Active

MFDS item code 201601231 · Approved 2016.02.29 · Insurance code 654004740

Summary

Main use
Improvement of primary hypercholesterolemia and mixed dyslipidemia
Who takes it
Adults
Adult dose
This medicine is administered once daily, with or without food. Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient’s baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dosage range is 10/5 mg to 10/20 mg once daily. The recommended starting dose is 10/5 mg once daily. The dose may be adjusted for patients who require a greater reduction in LDL cholesterol. After starting treatment or adjusting the dose, blood lipid levels should be checked at intervals of at least 4 weeks, and the dose adjusted accordingly. The dose may be increased to a maximum of 10/20 mg once daily. Patients taking ezetimibe and rosuvastatin concomitantly may switch to this medicine (a combination product with the same strengths of each active ingredient) for convenience.

Ingredients

Manufacturer
Aju Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of primary hypercholesterolemia and mixed dyslipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • elevated total cholesterol
  • elevated LDL cholesterol
  • elevated apolipoprotein B
  • elevated triglycerides
  • elevated non-HDL cholesterol
View approved original text

This medication helps lower total cholesterol, LDL cholesterol, apolipoprotein B, triglycerides, and non-HDL cholesterol levels in patients with primary hypercholesterolemia or mixed dyslipidemia, while increasing good HDL cholesterol levels. It is also used in conjunction with lipid-regulating medications in patients at high risk of atherosclerotic vascular disease due to hypercholesterolemia to contribute to the prevention of cardiovascular diseases. This medication serves as an adjunct to dietary management and is prescribed when dietary responses limiting saturated fat and cholesterol intake are insufficient. It is important to identify and treat other causes that may lead to dyslipidemia, such as diabetes or hypothyroidism, before starting the medication as needed. Regular lipid tests are necessary to monitor the treatment effects, especially in patients with acute coronary events, lipid levels should be checked at the time of admission or within 24 hours after admission. This medication is used to improve hypercholesterolemia and dyslipidemia.

How to take

Adult dose

This medicine is administered once daily, with or without food. Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient’s baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dosage range is 10/5 mg to 10/20 mg once daily. The recommended starting dose is 10/5 mg once daily. The dose may be adjusted for patients who require a greater reduction in LDL cholesterol. After starting treatment or adjusting the dose, blood lipid levels should be checked at intervals of at least 4 weeks, and the dose adjusted accordingly. The dose may be increased to a maximum of 10/20 mg once daily. Patients taking ezetimibe and rosuvastatin concomitantly may switch to this medicine (a combination product with the same strengths of each active ingredient) for convenience.

Precautions

This medication has been reported to rarely cause rhabdomyolysis, which can lead to serious kidney problems due to muscle tissue damage. Therefore, patients experiencing severe muscle pain or weakness, or those with risk factors such as severe infections, hypotension, major surgery, trauma, or serious metabolic disorders should temporarily discontinue or stop this medication. Patients allergic to components of this medication, those with active liver diseases, muscle disease patients, patients with severely impaired renal function, pregnant women, or nursing mothers should not take this medication. Moreover, patients with moderate to severe renal impairment, hypothyroidism, a family history of muscle disease, or those who are on specific medications that increase the risk of muscle damage should be particularly cautious when taking this medication. As this medication contains lactose, it should not be administered to patients with genetic issues such as lactose intolerance. Caution is also required in patients with a history of alcoholism or liver disease, moderate liver dysfunction, elderly patients, and those with risk factors for myopathy; special care is advised when combined with fibrate-type medications. If symptoms such as muscle pain, cramps, fatigue, or warmth occur while taking this medication, patients should notify their doctor immediately and be examined; in severe cases, the medication should be discontinued. Liver function abnormalities may appear, thus liver function tests should be conducted before and during treatment, and if liver enzyme levels increase significantly, the medication should be stopped. This medication may slightly raise blood glucose levels; however, the reduction of cardiovascular risks outweighs the potential risk of severe diabetes development, hence does not warrant discontinuation. It must be discontinued during pregnancy as it may be harmful to the fetus, and nursing mothers should avoid this medication as well. This medication is not recommended for children as its safety and efficacy have not been adequately established. Due to the risk of myopathy in the elderly, it should be used with caution. This medication may interact with other drugs, so patients should always inform their doctor or pharmacist of other medications they are taking, particularly with certain antibiotics, antivirals, anticoagulants, and fibrate-type drugs. There is no specific antidote for overdose; treatment is symptomatic, and liver function and muscle damage should be checked. Lastly, this medication should be kept out of reach of children and should not be transferred to another container.

Side effects

Acute renal failure due to myoglobinuria, rhabdomyolysis, nasopharyngitis, arthralgia, headache, elevated ALT, elevated AST, myalgia, edema, increased serum bilirubin, acneiform dermatitis, pruritus, dizziness, upper respiratory infection, chest pain, facial swelling, strange sensations, drug intolerance, colon polyps, irritable bowel syndrome, esophagitis, somnolence, neurodegenerative disorders, orthostatic dizziness, migraine, diabetes, impaired glucose tolerance, depression, bronchitis, rhinitis, cystitis, onychomycosis, soft tissue infection, fatty liver, hepatic dysfunction, hepatic toxicity, acute hepatitis, toxic hepatitis, increased gamma-glutamyl transferase, increased blood cholesterol, increased blood alkaline phosphatase, arrhythmia, osteoarthritis, osteoporosis, musculoskeletal stiffness, musculoskeletal discomfort, muscle weakness, diaphoresis, dermatitis, skin burning sensation, skin disorders, alopecia, oropharyngeal pain, nasal congestion, respiratory distress, pelvic pain, breast cyst, eyelid drooping, diabetic retinopathy, ear discomfort, renal dysfunction, benign esophageal neoplasm, polyneuropathy, memory loss, peripheral neuropathy, cough, dyspnea, diarrhea, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, myalgia, headache, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myopathy, rhabdomyolysis, asthenia, fatigue, numbness, paresthesia, chest discomfort, loss of appetite, abdominal distension, syncope, generalized pain, muscle cramps, gout, erectile dysfunction, thrombocytopenia, increased serum creatinine, acute renal failure, oliguria

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture, with a storage temperature maintained between 1 to 30 degrees Celsius in a cool, dry place. Proper storage will help maintain the effectiveness and safety of the medication for a longer duration.

Appearance and packaging

Appearance

White to almost white round film-coated tablet

Package unit

Blister - 30 tablets/blister [10 tablets/blister × 3], Bottle - 30 tablets/bottle, Bottle - 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.